Please use this identifier to cite or link to this item: https://doi.org/10.1039/c8sc00602d
Title: A halogen bond-mediated highly active artificial chloride channel with high anticancer activity
Authors: Ren, C. 
Ding, X.
Roy, A.
Shen, J.
Zhou, S.
Chen, F. 
Yau Li, S.F. 
Ren, H.
Yang, Y.Y.
Zeng, H. 
Issue Date: 2018
Publisher: Royal Society of Chemistry
Citation: Ren, C., Ding, X., Roy, A., Shen, J., Zhou, S., Chen, F., Yau Li, S.F., Ren, H., Yang, Y.Y., Zeng, H. (2018). A halogen bond-mediated highly active artificial chloride channel with high anticancer activity. Chemical Science 9 (17) : 4044-4051. ScholarBank@NUS Repository. https://doi.org/10.1039/c8sc00602d
Rights: Attribution-NonCommercial 4.0 International
Abstract: Chloride-selective transmembrane carriers or channels might have possible uses in treating channelopathies or cancers. While chloride carriers have been extensively investigated, the corresponding chloride channels have remained limitedly studied. Moreover, all hitherto reported channel systems lack clearly definable and readily modifiable positions in their structures for the reliable construction and combinatorial optimization of their ion transport properties. As a result, the existing channels are limited by their large molecular weight, weak activity or low anion selectivity. In this report, we describe a readily accessible and robust monopeptide-based scaffold for the reliable construction of halogen bond-mediated artificial anion channels via directional assembly of electron-deficient iodine atoms, which create a transmembrane pathway for facilitating anion transport. The high intrinsic modularity of the backbone of the scaffold, which enables the rapid and combinatorial optimization of the transport activity and selectivity of channels, effectively delivers a highly active chloride channel A10. Such high activity in chloride transport subsequently leads to an excellent IC50 value of 20 μM toward inhibiting the growth of human breast cancer cells (BT-474), an anticancer activity that is even higher than that of the well-known anticancer agent cisplatin. © 2018 The Royal Society of Chemistry.
Source Title: Chemical Science
URI: https://scholarbank.nus.edu.sg/handle/10635/210900
ISSN: 20416520
DOI: 10.1039/c8sc00602d
Rights: Attribution-NonCommercial 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1039_c8sc00602d.pdf3.65 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

59
checked on Oct 1, 2022

Page view(s)

61
checked on Sep 29, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons